BioCentury
ARTICLE | Politics, Policy & Law

Coronavirus bill includes antibiotic, net operating loss carryback, drug shortage provisions

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.

March 20, 2020 9:31 PM UTC
Updated on Mar 25, 2020 at 10:31 PM UTC

The phase three coronavirus stimulus bill that is expected to be signed into law next week is likely to include provisions that are intended to stimulate development of antibiotics, relax limits on carrying back net operating losses, mitigate drug shortages, and speed FDA review of medicines to treat and prevent COVID-19.

Republican Senate leaders are negotiating with Democrats in both houses of Congress on revisions to the CARES Act. A final vote is expected over the weekend or Monday. ...